Discover 3,557 paid clinical trials in Santa Ana, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,557
Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa
for
Epidermolysis Bullosa (EB)
Location: Rancho Santa Margarita CA, Redwood City CA,
Sponsor: Paradigm Therapeutics
Sex: All
Age: 0 - 12
Code: NCT07482787
Phase3, Recruiting
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Location: Los Angeles CA, Portland OR, Seattle WA, Houston TX,
Sponsor: Sun Pharmaceutical Industries Limited
Sex: Male
Age: 18+
Code: NCT05422911
Phase2, Recruiting
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
for
ARB, BVMD, Autosomal-Dominant Bestrophinopathy,
Location: Los Angeles CA, Dallas TX, Cincinnati OH
Sponsor: Opus Genetics, Inc
Sex: All
Age: 18+
Code: NCT07185256
Phase1, Phase2, Recruiting
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
for
Severe Hypertriglyceridemia
Location: Long Beach CA, Montclair CA, Northridge CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07269210
Phase2, Recruiting
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
for
Type 1 Diabetes (T1D), Type 1 Diabetes Mellitus
Location: Duarte CA, San Diego CA, San Francisco CA,
Sponsor: GentiBio, Inc
Sex: All
Age: 18 - 55
Code: NCT06919354
Phase1, Recruiting
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
for
Type 2 Diabetes
Location: Long Beach CA, Montclair CA, Canoga Park CA,
Sponsor: Biomea Fusion Inc.
Sex: All
Age: 18 - 70
Code: NCT07502508
Phase2, Recruiting
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
for
Type II Diabetes Mellitus
Location: Long Beach CA, Walnut Creek CA, Albuquerque NM,
Sponsor: Corxel Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07340320
Phase2, Recruiting
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
Location: Los Angeles CA, Greenville SC, Gainsville FL,
Sponsor: Recross Cardio, Inc.
Sex: All
Age: 18 - 65
Code: NCT07172464
Recruiting
Neoadjuvant Darovasertib in Primary Uveal Melanoma
for
Uveal Melanoma
Location: Riverside CA, Scottsdale AZ, Palo Alto CA, Aurora CO,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07015190
Phase3, Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
for
Metastatic HER2-positive Breast Cancer
Location: Cerritos CA, Los Angeles CA, Glendale CA, Phoenix AZ,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06435429
Phase3, Recruiting
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
for
Eosinophilic Asthma
Location: Long Beach CA, Upland CA, Northridge CA, Lancaster CA,
Sponsor: Kymera Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07323654
Phase2, Recruiting
New
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
for
Obesity, Overweight, Diabetes Mellitus, Type 2
Location: Cerritos CA, Pomona CA, Canoga Park CA, Chula Vista CA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07684144
Phase3, Recruiting
Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer
for
Localized Clear Cell Renal Cell Carcinoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07226544
Phase2, Recruiting
EXoPERT EMERALD Clinical Study
for
Breast Cancer, Colon Cancer, Pancreatic Cancer, Ovarian Cancer,
Location: Long Beach CA, Los Angeles CA, Louisville KY,
Sponsor: EXoPERT
Sex: All
Age: 45+
Code: NCT07186296
Recruiting
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,